SynthesisBreast (Edinburgh, Scotland)2025

Safety profile of sacituzumab govitecan in patients with breast cancer: A systematic review and meta-analysis.

Maria Inez Dacoregio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.